Cargando…

p53‐Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) accounts for 50% of patients with heart failure. Clinically, HFpEF prevalence shows age and gender biases. Although the majority of patients with HFpEF are elderly, there is an emergence of young patients with HFpEF. A better underst...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaonan, Lin, Hao, Xiong, Weiyao, Pan, Jianan, Huang, Shuying, Xu, Shan, He, Shufang, Lei, Ming, Chang, Alex Chia Yu, Zhang, Huili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238719/
https://www.ncbi.nlm.nih.gov/pubmed/35656994
http://dx.doi.org/10.1161/JAHA.121.024582
_version_ 1784737125705449472
author Chen, Xiaonan
Lin, Hao
Xiong, Weiyao
Pan, Jianan
Huang, Shuying
Xu, Shan
He, Shufang
Lei, Ming
Chang, Alex Chia Yu
Zhang, Huili
author_facet Chen, Xiaonan
Lin, Hao
Xiong, Weiyao
Pan, Jianan
Huang, Shuying
Xu, Shan
He, Shufang
Lei, Ming
Chang, Alex Chia Yu
Zhang, Huili
author_sort Chen, Xiaonan
collection PubMed
description BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) accounts for 50% of patients with heart failure. Clinically, HFpEF prevalence shows age and gender biases. Although the majority of patients with HFpEF are elderly, there is an emergence of young patients with HFpEF. A better understanding of the underlying pathogenic mechanism is urgently needed. Here, we aimed to determine the role of aging in the pathogenesis of HFpEF. METHODS AND RESULTS: HFpEF dietary regimen (high‐fat diet + Nω‐Nitro‐L‐arginine methyl ester hydrochloride) was used to induce HFpEF in wild type and telomerase RNA knockout mice (second‐generation and third‐generation telomerase RNA component knockout), an aging murine model. First, both male and female animals develop HFpEF equally. Second, cardiac wall thickening preceded diastolic dysfunction in all HFpEF animals. Third, accelerated HFpEF onset was observed in second‐generation telomerase RNA component knockout (at 6 weeks) and third‐generation telomerase RNA component knockout (at 4 weeks) compared with wild type (8 weeks). Fourth, we demonstrate that mitochondrial respiration transitioned from compensatory state (normal basal yet loss of maximal respiratory capacity) to dysfunction (loss of both basal and maximal respiratory capacity) in a p53 dosage dependent manner. Last, using myocardial‐specific p53 knockout animals, we demonstrate that loss of p53 activation delays the development of HFpEF. CONCLUSIONS: Here we demonstrate that p53 activation plays a role in the pathogenesis of HFpEF. We show that short telomere animals exhibit a basal level of p53 activation, mitochondria upregulate mtDNA encoded genes as a mean to compensate for blocked mitochondrial biogenesis, and loss of myocardial p53 delays HFpEF onset in high fat diet + Nω‐Nitro‐L‐arginine methyl ester hydrochloride challenged murine model.
format Online
Article
Text
id pubmed-9238719
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92387192022-06-30 p53‐Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction Chen, Xiaonan Lin, Hao Xiong, Weiyao Pan, Jianan Huang, Shuying Xu, Shan He, Shufang Lei, Ming Chang, Alex Chia Yu Zhang, Huili J Am Heart Assoc Original Research BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) accounts for 50% of patients with heart failure. Clinically, HFpEF prevalence shows age and gender biases. Although the majority of patients with HFpEF are elderly, there is an emergence of young patients with HFpEF. A better understanding of the underlying pathogenic mechanism is urgently needed. Here, we aimed to determine the role of aging in the pathogenesis of HFpEF. METHODS AND RESULTS: HFpEF dietary regimen (high‐fat diet + Nω‐Nitro‐L‐arginine methyl ester hydrochloride) was used to induce HFpEF in wild type and telomerase RNA knockout mice (second‐generation and third‐generation telomerase RNA component knockout), an aging murine model. First, both male and female animals develop HFpEF equally. Second, cardiac wall thickening preceded diastolic dysfunction in all HFpEF animals. Third, accelerated HFpEF onset was observed in second‐generation telomerase RNA component knockout (at 6 weeks) and third‐generation telomerase RNA component knockout (at 4 weeks) compared with wild type (8 weeks). Fourth, we demonstrate that mitochondrial respiration transitioned from compensatory state (normal basal yet loss of maximal respiratory capacity) to dysfunction (loss of both basal and maximal respiratory capacity) in a p53 dosage dependent manner. Last, using myocardial‐specific p53 knockout animals, we demonstrate that loss of p53 activation delays the development of HFpEF. CONCLUSIONS: Here we demonstrate that p53 activation plays a role in the pathogenesis of HFpEF. We show that short telomere animals exhibit a basal level of p53 activation, mitochondria upregulate mtDNA encoded genes as a mean to compensate for blocked mitochondrial biogenesis, and loss of myocardial p53 delays HFpEF onset in high fat diet + Nω‐Nitro‐L‐arginine methyl ester hydrochloride challenged murine model. John Wiley and Sons Inc. 2022-06-03 /pmc/articles/PMC9238719/ /pubmed/35656994 http://dx.doi.org/10.1161/JAHA.121.024582 Text en © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Chen, Xiaonan
Lin, Hao
Xiong, Weiyao
Pan, Jianan
Huang, Shuying
Xu, Shan
He, Shufang
Lei, Ming
Chang, Alex Chia Yu
Zhang, Huili
p53‐Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction
title p53‐Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction
title_full p53‐Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction
title_fullStr p53‐Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction
title_full_unstemmed p53‐Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction
title_short p53‐Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction
title_sort p53‐dependent mitochondrial compensation in heart failure with preserved ejection fraction
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238719/
https://www.ncbi.nlm.nih.gov/pubmed/35656994
http://dx.doi.org/10.1161/JAHA.121.024582
work_keys_str_mv AT chenxiaonan p53dependentmitochondrialcompensationinheartfailurewithpreservedejectionfraction
AT linhao p53dependentmitochondrialcompensationinheartfailurewithpreservedejectionfraction
AT xiongweiyao p53dependentmitochondrialcompensationinheartfailurewithpreservedejectionfraction
AT panjianan p53dependentmitochondrialcompensationinheartfailurewithpreservedejectionfraction
AT huangshuying p53dependentmitochondrialcompensationinheartfailurewithpreservedejectionfraction
AT xushan p53dependentmitochondrialcompensationinheartfailurewithpreservedejectionfraction
AT heshufang p53dependentmitochondrialcompensationinheartfailurewithpreservedejectionfraction
AT leiming p53dependentmitochondrialcompensationinheartfailurewithpreservedejectionfraction
AT changalexchiayu p53dependentmitochondrialcompensationinheartfailurewithpreservedejectionfraction
AT zhanghuili p53dependentmitochondrialcompensationinheartfailurewithpreservedejectionfraction